img

Global Electrocompetent Cells Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Electrocompetent Cells Market Research Report 2024

Electrocompetent cells work using the electroporation process. Electrical pulses created pores that allows genetic material to permeate the bacterial membrane. Invitrogen offers a variety of electrocompetent E. coli cells to reliably clone your DNA with high efficiency.
According to MRAResearch’s new survey, global Electrocompetent Cells market is projected to reach US$ 1335.4 million in 2033, increasing from US$ 713.7 million in 2022, with the CAGR of 9.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Electrocompetent Cells market research.
Key companies engaged in the Electrocompetent Cells industry include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Electrocompetent Cells were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Electrocompetent Cells market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Electrocompetent Cells market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells

Segment by Application


Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Electrocompetent Cells report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Electrocompetent Cells Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Cloned Competent Cells
1.2.3 Agrobacterium tumefaciens Competent Cells
1.2.4 Expression Competent Cells
1.3 Market by Application
1.3.1 Global Electrocompetent Cells Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable Dna Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded Dna Production
1.3.9 Bacmid creation
1.3.10 Cre-lox recombination (PIR1/PIR2)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Electrocompetent Cells Market Perspective (2018-2033)
2.2 Electrocompetent Cells Growth Trends by Region
2.2.1 Global Electrocompetent Cells Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Electrocompetent Cells Historic Market Size by Region (2018-2023)
2.2.3 Electrocompetent Cells Forecasted Market Size by Region (2024-2033)
2.3 Electrocompetent Cells Market Dynamics
2.3.1 Electrocompetent Cells Industry Trends
2.3.2 Electrocompetent Cells Market Drivers
2.3.3 Electrocompetent Cells Market Challenges
2.3.4 Electrocompetent Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Electrocompetent Cells Players by Revenue
3.1.1 Global Top Electrocompetent Cells Players by Revenue (2018-2023)
3.1.2 Global Electrocompetent Cells Revenue Market Share by Players (2018-2023)
3.2 Global Electrocompetent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Electrocompetent Cells Revenue
3.4 Global Electrocompetent Cells Market Concentration Ratio
3.4.1 Global Electrocompetent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Electrocompetent Cells Revenue in 2022
3.5 Electrocompetent Cells Key Players Head office and Area Served
3.6 Key Players Electrocompetent Cells Product Solution and Service
3.7 Date of Enter into Electrocompetent Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Electrocompetent Cells Breakdown Data by Type
4.1 Global Electrocompetent Cells Historic Market Size by Type (2018-2023)
4.2 Global Electrocompetent Cells Forecasted Market Size by Type (2024-2033)
5 Electrocompetent Cells Breakdown Data by Application
5.1 Global Electrocompetent Cells Historic Market Size by Application (2018-2023)
5.2 Global Electrocompetent Cells Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Electrocompetent Cells Market Size (2018-2033)
6.2 North America Electrocompetent Cells Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Electrocompetent Cells Market Size by Country (2018-2023)
6.4 North America Electrocompetent Cells Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Electrocompetent Cells Market Size (2018-2033)
7.2 Europe Electrocompetent Cells Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Electrocompetent Cells Market Size by Country (2018-2023)
7.4 Europe Electrocompetent Cells Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Electrocompetent Cells Market Size (2018-2033)
8.2 Asia-Pacific Electrocompetent Cells Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Electrocompetent Cells Market Size by Region (2018-2023)
8.4 Asia-Pacific Electrocompetent Cells Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Electrocompetent Cells Market Size (2018-2033)
9.2 Latin America Electrocompetent Cells Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Electrocompetent Cells Market Size by Country (2018-2023)
9.4 Latin America Electrocompetent Cells Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Electrocompetent Cells Market Size (2018-2033)
10.2 Middle East & Africa Electrocompetent Cells Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Electrocompetent Cells Market Size by Country (2018-2023)
10.4 Middle East & Africa Electrocompetent Cells Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Detail
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Electrocompetent Cells Introduction
11.1.4 Merck KGaA Revenue in Electrocompetent Cells Business (2018-2023)
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Electrocompetent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Electrocompetent Cells Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Electrocompetent Cells Introduction
11.3.4 Agilent Technologies Revenue in Electrocompetent Cells Business (2018-2023)
11.3.5 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Detail
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Electrocompetent Cells Introduction
11.4.4 Takara Bio Revenue in Electrocompetent Cells Business (2018-2023)
11.4.5 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Detail
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Electrocompetent Cells Introduction
11.5.4 Promega Corporation Revenue in Electrocompetent Cells Business (2018-2023)
11.5.5 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Detail
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Electrocompetent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Electrocompetent Cells Business (2018-2023)
11.6.5 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Detail
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Electrocompetent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Electrocompetent Cells Business (2018-2023)
11.7.5 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Detail
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Electrocompetent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Electrocompetent Cells Business (2018-2023)
11.8.5 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Detail
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Electrocompetent Cells Introduction
11.9.4 New England Biolabs Revenue in Electrocompetent Cells Business (2018-2023)
11.9.5 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Detail
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Electrocompetent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Electrocompetent Cells Business (2018-2023)
11.10.5 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Detail
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Electrocompetent Cells Introduction
11.11.4 OriGene Technologies Revenue in Electrocompetent Cells Business (2018-2023)
11.11.5 OriGene Technologies Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Detail
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Electrocompetent Cells Introduction
11.12.4 Lucigen Revenue in Electrocompetent Cells Business (2018-2023)
11.12.5 Lucigen Recent Development
11.13 Zymo Research
11.13.1 Zymo Research Company Detail
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Electrocompetent Cells Introduction
11.13.4 Zymo Research Revenue in Electrocompetent Cells Business (2018-2023)
11.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Detail
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Electrocompetent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Electrocompetent Cells Business (2018-2023)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
11.15.1 Bioline Company Detail
11.15.2 Bioline Business Overview
11.15.3 Bioline Electrocompetent Cells Introduction
11.15.4 Bioline Revenue in Electrocompetent Cells Business (2018-2023)
11.15.5 Bioline Recent Development
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Detail
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Electrocompetent Cells Introduction
11.16.4 Delphi Genetics Revenue in Electrocompetent Cells Business (2018-2023)
11.16.5 Delphi Genetics Recent Development
11.17 IBA GmBH
11.17.1 IBA GmBH Company Detail
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Electrocompetent Cells Introduction
11.17.4 IBA GmBH Revenue in Electrocompetent Cells Business (2018-2023)
11.17.5 IBA GmBH Recent Development
11.18 Cell Applications
11.18.1 Cell Applications Company Detail
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Electrocompetent Cells Introduction
11.18.4 Cell Applications Revenue in Electrocompetent Cells Business (2018-2023)
11.18.5 Cell Applications Recent Development
11.19 BioDynamics Laboratory
11.19.1 BioDynamics Laboratory Company Detail
11.19.2 BioDynamics Laboratory Business Overview
11.19.3 BioDynamics Laboratory Electrocompetent Cells Introduction
11.19.4 BioDynamics Laboratory Revenue in Electrocompetent Cells Business (2018-2023)
11.19.5 BioDynamics Laboratory Recent Development
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Detail
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Electrocompetent Cells Introduction
11.20.4 Scarab Genomics Revenue in Electrocompetent Cells Business (2018-2023)
11.20.5 Scarab Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Electrocompetent Cells Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Cloned Competent Cells
Table 3. Key Players of Agrobacterium tumefaciens Competent Cells
Table 4. Key Players of Expression Competent Cells
Table 5. Global Electrocompetent Cells Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Electrocompetent Cells Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Electrocompetent Cells Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Electrocompetent Cells Market Share by Region (2018-2023)
Table 9. Global Electrocompetent Cells Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Electrocompetent Cells Market Share by Region (2024-2033)
Table 11. Electrocompetent Cells Market Trends
Table 12. Electrocompetent Cells Market Drivers
Table 13. Electrocompetent Cells Market Challenges
Table 14. Electrocompetent Cells Market Restraints
Table 15. Global Electrocompetent Cells Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Electrocompetent Cells Market Share by Players (2018-2023)
Table 17. Global Top Electrocompetent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Electrocompetent Cells as of 2022)
Table 18. Ranking of Global Top Electrocompetent Cells Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Electrocompetent Cells Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Electrocompetent Cells Product Solution and Service
Table 22. Date of Enter into Electrocompetent Cells Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Electrocompetent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Electrocompetent Cells Revenue Market Share by Type (2018-2023)
Table 26. Global Electrocompetent Cells Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Electrocompetent Cells Revenue Market Share by Type (2024-2033)
Table 28. Global Electrocompetent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Electrocompetent Cells Revenue Market Share by Application (2018-2023)
Table 30. Global Electrocompetent Cells Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Electrocompetent Cells Revenue Market Share by Application (2024-2033)
Table 32. North America Electrocompetent Cells Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Electrocompetent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Electrocompetent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Electrocompetent Cells Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Electrocompetent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Electrocompetent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Electrocompetent Cells Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Electrocompetent Cells Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Electrocompetent Cells Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Electrocompetent Cells Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Electrocompetent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Electrocompetent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Electrocompetent Cells Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Electrocompetent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Electrocompetent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 47. Merck KGaA Company Detail
Table 48. Merck KGaA Business Overview
Table 49. Merck KGaA Electrocompetent Cells Product
Table 50. Merck KGaA Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 51. Merck KGaA Recent Development
Table 52. Thermo Fisher Scientific Company Detail
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific Electrocompetent Cells Product
Table 55. Thermo Fisher Scientific Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 56. Thermo Fisher Scientific Recent Development
Table 57. Agilent Technologies Company Detail
Table 58. Agilent Technologies Business Overview
Table 59. Agilent Technologies Electrocompetent Cells Product
Table 60. Agilent Technologies Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 61. Agilent Technologies Recent Development
Table 62. Takara Bio Company Detail
Table 63. Takara Bio Business Overview
Table 64. Takara Bio Electrocompetent Cells Product
Table 65. Takara Bio Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 66. Takara Bio Recent Development
Table 67. Promega Corporation Company Detail
Table 68. Promega Corporation Business Overview
Table 69. Promega Corporation Electrocompetent Cells Product
Table 70. Promega Corporation Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 71. Promega Corporation Recent Development
Table 72. Beijing TransGen Biotech Company Detail
Table 73. Beijing TransGen Biotech Business Overview
Table 74. Beijing TransGen Biotech Electrocompetent Cells Product
Table 75. Beijing TransGen Biotech Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 76. Beijing TransGen Biotech Recent Development
Table 77. GeneScript Corporation Company Detail
Table 78. GeneScript Corporation Business Overview
Table 79. GeneScript Corporation Electrocompetent Cells Product
Table 80. GeneScript Corporation Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 81. GeneScript Corporation Recent Development
Table 82. Yeastern Biotech Company Detail
Table 83. Yeastern Biotech Business Overview
Table 84. Yeastern Biotech Electrocompetent Cells Product
Table 85. Yeastern Biotech Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 86. Yeastern Biotech Recent Development
Table 87. New England Biolabs Company Detail
Table 88. New England Biolabs Business Overview
Table 89. New England Biolabs Electrocompetent Cells Product
Table 90. New England Biolabs Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 91. New England Biolabs Recent Development
Table 92. QIAGEN N.V. Company Detail
Table 93. QIAGEN N.V. Business Overview
Table 94. QIAGEN N.V. Electrocompetent Cells Product
Table 95. QIAGEN N.V. Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 96. QIAGEN N.V. Recent Development
Table 97. OriGene Technologies Company Detail
Table 98. OriGene Technologies Business Overview
Table 99. OriGene Technologies Electrocompetent Cells Product
Table 100. OriGene Technologies Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 101. OriGene Technologies Recent Development
Table 102. Lucigen Company Detail
Table 103. Lucigen Business Overview
Table 104. Lucigen Electrocompetent Cells Product
Table 105. Lucigen Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 106. Lucigen Recent Development
Table 107. Zymo Research Company Detail
Table 108. Zymo Research Business Overview
Table 109. Zymo Research Electrocompetent Cells Product
Table 110. Zymo Research Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 111. Zymo Research Recent Development
Table 112. Bio-Rad Laboratories Company Detail
Table 113. Bio-Rad Laboratories Business Overview
Table 114. Bio-Rad Laboratories Electrocompetent Cells Product
Table 115. Bio-Rad Laboratories Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 116. Bio-Rad Laboratories Recent Development
Table 117. Bioline Company Detail
Table 118. Bioline Business Overview
Table 119. Bioline Electrocompetent Cells Product
Table 120. Bioline Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 121. Bioline Recent Development
Table 122. Delphi Genetics Company Detail
Table 123. Delphi Genetics Business Overview
Table 124. Delphi Genetics Electrocompetent Cells Product
Table 125. Delphi Genetics Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 126. Delphi Genetics Recent Development
Table 127. IBA GmBH Company Detail
Table 128. IBA GmBH Business Overview
Table 129. IBA GmBH Electrocompetent Cells Product
Table 130. IBA GmBH Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 131. IBA GmBH Recent Development
Table 132. Cell Applications Company Detail
Table 133. Cell Applications Business Overview
Table 134. Cell Applications Electrocompetent Cells Product
Table 135. Cell Applications Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 136. Cell Applications Recent Development
Table 137. BioDynamics Laboratory Company Detail
Table 138. BioDynamics Laboratory Business Overview
Table 139. BioDynamics Laboratory Electrocompetent Cells Product
Table 140. BioDynamics Laboratory Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 141. BioDynamics Laboratory Recent Development
Table 142. Scarab Genomics Company Detail
Table 143. Scarab Genomics Business Overview
Table 144. Scarab Genomics Electrocompetent Cells Product
Table 145. Scarab Genomics Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 146. Scarab Genomics Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Electrocompetent Cells Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Electrocompetent Cells Market Share by Type: 2022 VS 2033
Figure 3. Cloned Competent Cells Features
Figure 4. Agrobacterium tumefaciens Competent Cells Features
Figure 5. Expression Competent Cells Features
Figure 6. Global Electrocompetent Cells Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Electrocompetent Cells Market Share by Application: 2022 VS 2033
Figure 8. Subcloning & Routine Cloning Case Studies
Figure 9. Phage Display Library Construction Case Studies
Figure 10. Toxic/Unstable Dna Cloning Case Studies
Figure 11. High-Throughput Cloning Case Studies
Figure 12. Protein Expression Case Studies
Figure 13. Mutagenesis Case Studies
Figure 14. Single-Stranded Dna Production Case Studies
Figure 15. Bacmid creation Case Studies
Figure 16. Cre-lox recombination (PIR1/PIR2) Case Studies
Figure 17. Electrocompetent Cells Report Years Considered
Figure 18. Global Electrocompetent Cells Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 19. Global Electrocompetent Cells Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 20. Global Electrocompetent Cells Market Share by Region: 2022 VS 2033
Figure 21. Global Electrocompetent Cells Market Share by Players in 2022
Figure 22. Global Top Electrocompetent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Electrocompetent Cells as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Electrocompetent Cells Revenue in 2022
Figure 24. North America Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. North America Electrocompetent Cells Market Share by Country (2018-2033)
Figure 26. United States Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Europe Electrocompetent Cells Market Share by Country (2018-2033)
Figure 30. Germany Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Asia-Pacific Electrocompetent Cells Market Share by Region (2018-2033)
Figure 38. China Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Japan Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. South Korea Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Southeast Asia Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. India Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Australia Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Latin America Electrocompetent Cells Market Share by Country (2018-2033)
Figure 46. Mexico Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Brazil Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa Electrocompetent Cells Market Share by Country (2018-2033)
Figure 50. Turkey Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Saudi Arabia Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Merck KGaA Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 54. Agilent Technologies Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 55. Takara Bio Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 56. Promega Corporation Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 57. Beijing TransGen Biotech Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 58. GeneScript Corporation Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 59. Yeastern Biotech Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 60. New England Biolabs Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 61. QIAGEN N.V. Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 62. OriGene Technologies Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 63. Lucigen Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 64. Zymo Research Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 65. Bio-Rad Laboratories Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 66. Bioline Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 67. Delphi Genetics Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 68. IBA GmBH Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 69. Cell Applications Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 70. BioDynamics Laboratory Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 71. Scarab Genomics Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed